Drugmakers Agree to Wait on Advertising New Drugs; Congressional Hearing Focused on Pfizer Inc.'s Lipitor, Johnson & Johnson's Procrit, and Vytorin Sold by Merck & Co., Inc. and Schering-Plough Pharmaceuticals

Published: Jun 18, 2008

Wall Street Journal -- Drugmakers called before Congress to explain their direct-to-consumer ads have agreed to wait six months before advertising newly approved drugs to the general public.

Back to news